Nancy Daly Ms Mph
EVP & CONQUER CANCER CEO at AMERICAN SOCIETY OF CLINICAL ONCOLOGY · VA · Disease Research
$517K
Peak Total Compensation
6
Years Tracked
7x
vs. Median Household
Nancy Daly Ms Mph has appeared in compensation disclosures over 6 years of available data (2016–2022). Total compensation changed from $350,079 to $516,841 - a 47.6% increase.
Peak total compensation of $516,841 equals 7x the median U.S. household income ($75,000).
Compensation History
Year-by-Year Detail
| Year | Organization | Title | Compensation | Other | Total |
|---|---|---|---|---|---|
| 2022 | AMERICAN SOCIETY OF CLINICAL ONCOLOGY | EVP & CONQUER CANCER CEO | $477,749 | $39,092 | $516,841 |
| 2020 | AMERICAN SOCIETY OF CLINICAL ONCOLOGY INC | EVP & CEO CONQUER CANCER FDN | $412,571 | $41,796 | $454,367 |
| 2019 | AMERICAN SOCIETY OF CLINICAL ONCOLOGY INC | EVP, CHIEF PHILANTHROPIC OFF. | $387,673 | $38,537 | $426,210 |
| 2018 | AMERICAN SOCIETY OF CLINICAL ONCOLOGY INC | Executive DIRECTOR | $369,808 | $38,168 | $407,976 |
| 2017 | AMERICAN SOCIETY OF CLINICAL ONCOLOGY INC | Executive VP, CPO, CC | $362,097 | $33,799 | $395,896 |
| 2016 | AMERICAN SOCIETY OF CLINICAL ONCOLOGY INC | Exe VP & chief phil offc, CCF | $316,634 | $33,445 | $350,079 |
Peers at AMERICAN SOCIETY OF CLINICAL ONCOLOGY
| Name | Title | Peak Comp. |
|---|---|---|
| Clifford Hudis Md | Chief Executive Officer | $972K |
| Clifford A Hudis Md | CEO | $953K |
| Clifford Hudismd | CEO, NON-VOTING DIRECTOR | $922K |
| Clifford Ahudismdfacpfasco | CEO, Ex-officio Director | $832K |
| Dina Michels Esq | SECRETARY, EVP & COO | $669K |
| Richard Schilsky Md | EVP & Chief Medical Officer | $660K |
| Julie R Gralow Md | EVP & CMO | $623K |
| Allen S Lichter Md Fasco | CEO, Ex-officio Dir (non-vote) | $601K |
| Cory Wiegert | EVP & CEO, CancerLinQ | $564K |
| Sean Khozin Md | EVP & CLQ CEO (PARTIAL YEAR) | $537K |
Email Alerts
Get notified about Nancy Daly Ms Mph
Get an email when a new IRS Form 990 filing is posted that includes this executive. We send a confirmation link first - we don't add you to any other list.
Compare with another executive: Open comparison tool →